Faes Farma Competitors and Similar CompaniesClear all
Faes Farma's competitors and similar companies include STADA, EyePoint Pharmaceuticals, Karyopharm Therapeutics and Apeloa Pharmaceutical.
 Faes Farma Faes Farma is a pharmaceutical company that develops, produces and commercializes pharmaceutical products and raw materials. |  EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. |  Karyopharm Therapeutics Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies. |  Apeloa Pharmaceutical Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products. | ||
Founding Date | Founding Date 1933 | Founding Date 1895 | Founding Date 1987 | Founding Date 2008 | Founding Date 1989 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Leioa, ES HQ Madrid, ES Atlanta, US | Locations Bad Vilbel, DE HQ Beijing, CN Hangzhou Shi, CN Shanghai, CN Bad Vilbel, DE Budapest, HU Vilnius, LT see more | Locations Watertown, US HQ | Locations Newton, US HQ Givatayim, IL | Locations CN HQ |
Employees | Employees 1,775 | Employees 12,33911% increase | Employees 8453% increase | Employees 22818% decrease | Employees 7,060 |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 6 b | Valuation ($) 617.6 m | Valuation ($) 111.7 m | Valuation ($) 2.7 b |
Financial | |||||
Revenue (est.) | Revenue (est.) €493.6m (FY, 2024) | Revenue (est.) €3b (FY, 2020) | Revenue (est.) $31.4m (FY, 2025) | Revenue (est.) $146.1m (FY, 2025) | Revenue (est.) ¥9.7b (FY, 2025) |
Cost of goods | Cost of goods €167.1m (FY, 2024) | Cost of goods €1.3b (FY, 2020) | Cost of goods N/A | Cost of goods $5.9m (FY, 2025) | Cost of goods ¥7.2b (FY, 2025) |
Gross profit | Gross profit €342.9m (FY, 2024) | Gross profit €1.7b (FY, 2020) | Gross profit N/A | Gross profit $140.1m (FY, 2025) | Gross profit ¥2.5b (FY, 2025) |
Net income | Net income €111.1m (FY, 2024) | Net income €181.9m (FY, 2020) | Net income ($232m) (FY, 2025) | Net income ($196m) (FY, 2025) | Net income ¥890.7m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 40m | Total funding raised $ 248.7m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
STADA
HQ
Bad Vilbel, DE
Employees
12,339↑ 11% increase
STADA Arzneimittel is a company engaged in the healthcare and pharmaceuticals business.
View companyEyePoint Pharmaceuticals
HQ
Watertown, US
Employees
84
EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.
View companyKaryopharm Therapeutics
HQ
Newton, US
Employees
228↓ 18% decrease
Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies.
View companyApeloa Pharmaceutical
HQ
CN
Employees
7,060
Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products.
View company